Rubius Therapeutics Inc. (RUBY) Dropped -5.12% or -1.02 To Price $18.89 On Friday


Rubius Therapeutics Inc. (RUBY) dropped -5.12% or -1.02 to $18.89. It is near to 123846 shares traded, which is 64.32% compare to the average total volume 192556. The market cap of RUBY is $1.49 billion. The year to date change is -23.02%. The 52 week price range is from $18.6 to $33.01. Price of RUBY have changed -17.04% during last week. It have changed -19.23% over last month, -17.90% over last 3 months, -17.90% over last 6 months and -17.90% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RUBY is 22.49. It is 19.06% above current price. The 52-week High is 33.01. It is 74.75% from the current price. The 52-week Low is 18.6. It is -1.54% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RUBY is 9.58 on 2018-09-14. Short % to float is 1.78%. There are some statistics of RUBY. It is has market cap $1.49 billion. The share outstanding is 79.04 million. The average volume is 192556. The percent of top 15 Institution holding is 7.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RUBY is 104.36%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RUBY is -35.56%.


Tags:

Share this post